Log In
Print
BCIQ
Print
Print this Print this
 

AR-301 (formerly KBSA301)

  Manage Alerts
Collapse Summary General Information
Company Aridis Pharmaceuticals LLC
DescriptionHuman IgG1 mAb generated using the MabIgX technology
Molecular Target S. aureus alpha-hemolysin (aHL)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today